{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:38:52Z","timestamp":1790779132182,"version":"4.1.0"},"reference-count":94,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T00:00:00Z","timestamp":1651104000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Evidence about the involvement of genetic factors in the development of gambling disorder (GD) has been assessed. Among studies assessing heritability and biological vulnerability for GD, neurotrophin (NTF) genes have\u00a0emerged as promising targets, since a growing literature showed a possible link between NTF and addiction-related disorders. Thus, we aimed to explore the role of NTF genes and GD with the hypothesis that some NTF gene polymorphisms could constitute biological risk factors. The sample included 166 patients with GD and 191 healthy controls. 36 single nucleotide polymorphisms (SNPs) from NTFs (NGF, NGFR, NTRK1, BDNF, NTRK2, NTF3, NTRK3, NTF4, CNTF and CNTFR) were selected and genotyped. Linkage disequilibrium (LD) and haplotype constructions were analyzed, in relationship with the presence of GD. Finally, regulatory elements overlapping the identified SNPs variants associated with GD were searched. The between groups comparisons of allele frequencies indicated that 6 SNPs were potentially associated with GD. Single and multiple-marker analyses showed a strong association between both NTF3 and NTRK2 genes, and GD. The present study supports the involvement of the NTF family in the aetiopathogenesis of GD. An altered cross-regulation of different NTF members signalling pathways might be considered as a biological vulnerability factor for GD.<\/jats:p>","DOI":"10.1038\/s41598-022-10391-w","type":"journal-article","created":{"date-parts":[[2022,4,28]],"date-time":"2022-04-28T09:03:47Z","timestamp":1651136627000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["The role of neurotrophin genes involved in the vulnerability to gambling disorder"],"prefix":"10.1038","volume":"12","author":[{"given":"Neus","family":"Sol\u00e9-Morata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Baenas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikel","family":"Etxandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roser","family":"Granero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia V.","family":"Forcales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Gen\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carme","family":"Barrot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f3nica","family":"G\u00f3mez-Pe\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 M.","family":"Mench\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00e1s","family":"Ramoz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Gorwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Fern\u00e1ndez-Aranda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana","family":"Jim\u00e9nez-Murcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,4,28]]},"reference":[{"key":"10391_CR1","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4614-3390-3","volume-title":"Internet Gambling","author":"S Gainsbury","year":"2012","unstructured":"Gainsbury, S. Internet Gambling 1st edn. (Springer, 2012).","edition":"1"},{"key":"10391_CR2","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1001\/jama.286.2.141","volume":"286","author":"MN Potenza","year":"2001","unstructured":"Potenza, M. N., Kosten, T. R. & Rounsaville, B. J. Pathological gambling. JAMA 286, 141 (2001).","journal-title":"JAMA"},{"key":"10391_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/mpr.354","volume":"20","author":"M Sassen","year":"2011","unstructured":"Sassen, M., Kraus, L. & B\u00fchringer, G. Differences in pathological gambling prevalence estimates: facts or artefacts?. Int. J. Methods Psychiatr. Res. 20, 1\u201310 (2011).","journal-title":"Int. J. Methods Psychiatr. Res."},{"key":"10391_CR4","unstructured":"DGOJ. Direcci\u00f3n General de Ordenaci\u00f3n del Juego. Memoria Anual 2015. (2015)."},{"key":"10391_CR5","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-09486-1","volume-title":"Problem Gambling in Europe: Challenges, Prevention, and Interventions","author":"M Griffiths","year":"2009","unstructured":"Griffiths, M., Hayer, T. & Meyer, G. Problem Gambling in Europe: Challenges, Prevention, and Interventions (Springer, 2009). https:\/\/doi.org\/10.1007\/978-0-387-09486-1."},{"key":"10391_CR6","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.ijlp.2013.11.002","volume":"37","author":"S Planzer","year":"2014","unstructured":"Planzer, S., Gray, H. M. & Shaffer, H. J. Associations between national gambling policies and disordered gambling prevalence rates within Europe. Int. J. Law Psychiatry 37, 217\u2013229 (2014).","journal-title":"Int. J. Law Psychiatry"},{"key":"10391_CR7","doi-asserted-by":"publisher","DOI":"10.1176\/appi.books.9780890425596","volume-title":"DSM-III: Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"1980","unstructured":"APA. DSM-III: Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 1980). https:\/\/doi.org\/10.1176\/appi.books.9780890425596."},{"key":"10391_CR8","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/j.1360-0443.2006.01591.x","volume":"101","author":"MN Potenza","year":"2006","unstructured":"Potenza, M. N. Should addictive disorders include non-substance-related conditions?. Addiction 101, 142\u2013151 (2006).","journal-title":"Addiction"},{"key":"10391_CR9","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.psychres.2008.06.036","volume":"170","author":"MN Potenza","year":"2009","unstructured":"Potenza, M. N., Koran, L. M. & Pallanti, S. The relationship between impulse-control disorders and obsessive\u2013compulsive disorder: A current understanding and future research directions. Psychiatry Res. 170, 22\u201331 (2009).","journal-title":"Psychiatry Res."},{"key":"10391_CR10","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"APA","year":"2013","unstructured":"APA. Diagnostic and Statistical Manual of Mental Disorders (American Psychiatric Association, 2013)."},{"key":"10391_CR11","doi-asserted-by":"publisher","first-page":"885","DOI":"10.1111\/adb.12378","volume":"22","author":"M Fauth-B\u00fchler","year":"2017","unstructured":"Fauth-B\u00fchler, M., Mann, K. & Potenza, M. N. Pathological gambling: A review of the neurobiological evidence relevant for its classification as an addictive disorder. Addict. Biol. 22, 885\u2013897 (2017).","journal-title":"Addict. Biol."},{"key":"10391_CR12","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.cpr.2016.10.008","volume":"51","author":"NA Dowling","year":"2017","unstructured":"Dowling, N. A. et al. Early risk and protective factors for problem gambling: A systematic review and meta-analysis of longitudinal studies. Clin. Psychol. Rev. 51, 109\u2013124 (2017).","journal-title":"Clin. Psychol. Rev."},{"key":"10391_CR13","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41572-019-0099-7","volume":"5","author":"MN Potenza","year":"2019","unstructured":"Potenza, M. N. et al. Gambling disorder. Nat. Rev. Dis. Prim. 5, 51 (2019).","journal-title":"Nat. Rev. Dis. Prim."},{"key":"10391_CR14","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1192\/bjp.162.3.407","volume":"162","author":"L Sharpe","year":"1993","unstructured":"Sharpe, L. & Tarrier, N. Towards a cognitive-behavioural theory of problem gambling. Br. J. Psychiatry 162, 407\u2013412 (1993).","journal-title":"Br. J. Psychiatry"},{"key":"10391_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0272-7358(00)00087-8","volume":"22","author":"L Sharpe","year":"2002","unstructured":"Sharpe, L. A reformulated cognitive\u2013behavioral model of problem gambling. Clin. Psychol. Rev. 22, 1\u201325 (2002).","journal-title":"Clin. Psychol. Rev."},{"key":"10391_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1046\/j.1360-0443.2002.00015.x","volume":"97","author":"A Blaszczynski","year":"2002","unstructured":"Blaszczynski, A. & Nower, L. A pathways model of problem and pathological gambling. Addiction 97, 487\u2013499 (2002).","journal-title":"Addiction"},{"key":"10391_CR17","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10899-015-9545-y","volume":"32","author":"M Valleur","year":"2016","unstructured":"Valleur, M. et al. Towards a validation of the three pathways model of pathological gambling. J. Gambl. Stud. 32, 757\u2013771 (2016).","journal-title":"J. Gambl. Stud."},{"key":"10391_CR18","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1177\/070674371305800503","volume":"58","author":"RF Leeman","year":"2013","unstructured":"Leeman, R. F. & Potenza, M. N. A targeted review of the neurobiology and genetics of behavioural addictions: An emerging area of research. Can. J. Psychiatry 58, 260\u2013273 (2013).","journal-title":"Can. J. Psychiatry"},{"key":"10391_CR19","first-page":"187","volume":"8","author":"VV Olsen","year":"2015","unstructured":"Olsen, V. V., Lugo, R. G., S\u00fctterlin, S., Olsen, V. V. & Lugo, R. G. The somatic marker theory in the context of addiction: Contributions to understanding development and maintenance. Psychol. Res. Behav. Manag. 8, 187 (2015).","journal-title":"Psychol. Res. Behav. Manag."},{"key":"10391_CR20","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1007\/s00429-013-0668-6","volume":"220","author":"S Koehler","year":"2015","unstructured":"Koehler, S., Hasselmann, E., W\u00fcstenberg, T., Heinz, A. & Romanczuk-Seiferth, N. Higher volume of ventral striatum and right prefrontal cortex in pathological gambling. Brain Struct. Funct. 220, 469\u2013477 (2015).","journal-title":"Brain Struct. Funct."},{"key":"10391_CR21","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1111\/add.13076","volume":"110","author":"O Contreras-Rodr\u00edguez","year":"2015","unstructured":"Contreras-Rodr\u00edguez, O. et al. Cocaine-specific neuroplasticity in the ventral striatum network is linked to delay discounting and drug relapse. Addiction 110, 1953\u20131962 (2015).","journal-title":"Addiction"},{"key":"10391_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuroimage.2012.06.067","volume":"63","author":"L Clark","year":"2012","unstructured":"Clark, L. et al. Striatal dopamine D2\/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage 63, 40\u201346 (2012).","journal-title":"Neuroimage"},{"key":"10391_CR23","doi-asserted-by":"publisher","first-page":"778","DOI":"10.1016\/j.biopsych.2016.12.022","volume":"81","author":"P Charbogne","year":"2017","unstructured":"Charbogne, P. et al. Mu opioid receptors in gamma-aminobutyric acidergic forebrain neurons moderate motivation for heroin and palatable food. Biol. Psychiatry 81, 778\u2013788 (2017).","journal-title":"Biol. Psychiatry"},{"key":"10391_CR24","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/mp.2013.163","volume":"19","author":"I Boileau","year":"2014","unstructured":"Boileau, I. et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: A positron emission tomography study with [11C]-(+)-PHNO. Mol. Psychiatry 19, 1305\u20131313 (2014).","journal-title":"Mol. Psychiatry"},{"key":"10391_CR25","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1111\/j.1360-0443.2009.02671.x","volume":"104","author":"DSS Lobo","year":"2009","unstructured":"Lobo, D. S. S. & Kennedy, J. L. Genetic aspects of pathological gambling: A complex disorder with shared genetic vulnerabilities. Addiction 104, 1454\u20131465 (2009).","journal-title":"Addiction"},{"key":"10391_CR26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s13072-015-0050-4","volume":"8","author":"YG Tak","year":"2015","unstructured":"Tak, Y. G. & Farnham, P. J. Making sense of GWAS: Using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome. Epigenet. Chrom. 8, 57 (2015).","journal-title":"Epigenet. Chrom."},{"key":"10391_CR27","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1111\/j.1369-1600.2012.00463.x","volume":"18","author":"PA Lind","year":"2013","unstructured":"Lind, P. A. et al. Genome-wide association study of a quantitative disordered gambling trait. Addict. Biol. 18, 511\u2013522 (2013).","journal-title":"Addict. Biol."},{"key":"10391_CR28","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/j.eurpsy.2016.04.001","volume":"36","author":"M Lang","year":"2016","unstructured":"Lang, M. et al. Genome-wide association study of pathological gambling. Eur. Psychiatry 36, 38\u201346 (2016).","journal-title":"Eur. Psychiatry"},{"key":"10391_CR29","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1016\/j.parkreldis.2020.03.017","volume":"75","author":"J Ihle","year":"2020","unstructured":"Ihle, J. et al. Parkinson\u2019s disease polygenic risk score is not associated with impulse control disorders: A longitudinal study. Parkinsonism Relat. Disord. 75, 30\u201333 (2020).","journal-title":"Parkinsonism Relat. Disord."},{"key":"10391_CR30","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1016\/j.nbd.2016.05.010","volume":"97","author":"M Koskela","year":"2017","unstructured":"Koskela, M. et al. Update of neurotrophic factors in neurobiology of addiction and future directions. Neurobiol. Dis. 97, 189\u2013200 (2017).","journal-title":"Neurobiol. Dis."},{"key":"10391_CR31","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1007\/978-3-642-45106-5_17","volume":"220","author":"E Castr\u00e9n","year":"2014","unstructured":"Castr\u00e9n, E. Neurotrophins and psychiatric disorders. Handb. Exp. Pharmacol. 220, 461\u2013479 (2014).","journal-title":"Handb. Exp. Pharmacol."},{"key":"10391_CR32","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1016\/j.jpsychires.2010.01.009","volume":"44","author":"M Gratac\u00f2s","year":"2010","unstructured":"Gratac\u00f2s, M. et al. Role of the neurotrophin network in eating disorders\u2019 subphenotypes: Body mass index and age at onset of the disease. J. Psychiatr. Res. 44, 834\u2013840 (2010).","journal-title":"J. Psychiatr. Res."},{"key":"10391_CR33","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1159\/000120623","volume":"56","author":"JM Mercader","year":"2007","unstructured":"Mercader, J. M. et al. Blood levels of brain-derived neurotrophic factor correlate with several psychopathological symptoms in anorexia nervosa patients. Neuropsychobiology 56, 185\u2013190 (2007).","journal-title":"Neuropsychobiology"},{"key":"10391_CR34","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1016\/j.pneurobio.2005.10.006","volume":"77","author":"NF Schor","year":"2005","unstructured":"Schor, N. F. The p75 neurotrophin receptor in human development and disease. Prog. Neurobiol. 77, 201\u2013214 (2005).","journal-title":"Prog. Neurobiol."},{"key":"10391_CR35","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1038\/nrn1726","volume":"6","author":"B Lu","year":"2005","unstructured":"Lu, B., Pang, P. T. & Woo, N. H. The yin and yang of neurotrophin action. Nat. Rev. Neurosci. 6, 603\u2013614 (2005).","journal-title":"Nat. Rev. Neurosci."},{"key":"10391_CR36","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1111\/j.1369-1600.2011.00411.x","volume":"18","author":"F Angelucci","year":"2013","unstructured":"Angelucci, F. et al. Enhanced BDNF serum levels in patients with severe pathological gambling. Addict. Biol. 18, 749\u2013751 (2013).","journal-title":"Addict. Biol."},{"key":"10391_CR37","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1556\/2006.5.2016.010","volume":"5","author":"S-WW Choi","year":"2016","unstructured":"Choi, S.-W.W. et al. Serum BDNF levels in patients with gambling disorder are associated with the severity of gambling disorder and Iowa Gambling Task indices. J. Behav. Addict. 5, 135\u2013139 (2016).","journal-title":"J. Behav. Addict."},{"key":"10391_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1159\/000338281","volume":"18","author":"O Geisel","year":"2012","unstructured":"Geisel, O., Banas, R., Hellweg, R. & M\u00fcller, C. A. altered serum levels of brain-derived neurotrophic factor in patients with pathological gambling. Eur. Addict. Res. 18, 297\u2013301 (2012).","journal-title":"Eur. Addict. Res."},{"key":"10391_CR39","doi-asserted-by":"publisher","first-page":"508","DOI":"10.1002\/erv.2606","volume":"26","author":"HS Kim","year":"2018","unstructured":"Kim, H. S., von Ranson, K. M., Hodgins, D. C., McGrath, D. S. & Tavares, H. Demographic, psychiatric, and personality correlates of adults seeking treatment for disordered gambling with a comorbid binge\/purge type eating disorder. Eur. Eat. Disord. Rev. 26, 508\u2013518 (2018).","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10391_CR40","doi-asserted-by":"publisher","first-page":"4201","DOI":"10.1038\/s41598-017-04476-0","volume":"7","author":"M Chorev","year":"2017","unstructured":"Chorev, M., Joseph Bekker, A., Goldberger, J. & Carmel, L. Identification of introns harboring functional sequence elements through positional conservation. Sci. Rep. 7, 4201 (2017).","journal-title":"Sci. Rep."},{"key":"10391_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-020-0759-8","author":"F Ji","year":"2020","unstructured":"Ji, F., Wang, W., Feng, C., Gao, F. & Jiao, J. Brain-specific Wt1 deletion leads to depressive-like behaviors in mice via the recruitment of Tet2 to modulate Epo expression. Mol. Psychiatry https:\/\/doi.org\/10.1038\/s41380-020-0759-8 (2020).","journal-title":"Mol. Psychiatry"},{"key":"10391_CR42","doi-asserted-by":"publisher","first-page":"598","DOI":"10.1210\/me.2012-1371","volume":"27","author":"SD Atkin","year":"2013","unstructured":"Atkin, S. D. et al. Nuclear receptor LRH-1 induces the reproductive neuropeptide kisspeptin in the hypothalamus. Mol. Endocrinol. 27, 598\u2013605 (2013).","journal-title":"Mol. Endocrinol."},{"key":"10391_CR43","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.immuni.2013.11.022","volume":"40","author":"Y Yoshida","year":"2014","unstructured":"Yoshida, Y. et al. The transcription factor IRF8 activates integrin-mediated tgf-\u03b2 signaling and promotes neuroinflammation. Immunity 40, 187\u2013198 (2014).","journal-title":"Immunity"},{"key":"10391_CR44","doi-asserted-by":"publisher","first-page":"939","DOI":"10.1387\/ijdb.092974ms","volume":"54","author":"M Di Salvio","year":"2010","unstructured":"Di Salvio, M., Di Giovannantonio, L. G., Omodei, D., Acampora, D. & Simeone, A. Otx2 expression is restricted to dopaminergic neurons of the ventral tegmental area in the adult brain. Int. J. Dev. Biol. 54, 939\u2013945 (2010).","journal-title":"Int. J. Dev. Biol."},{"key":"10391_CR45","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1097\/00008571-199606000-00004","volume":"6","author":"DE Comings","year":"1996","unstructured":"Comings, D. E. et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics 6, 223\u2013234 (1996).","journal-title":"Pharmacogenetics"},{"key":"10391_CR46","doi-asserted-by":"publisher","first-page":"887","DOI":"10.1038\/mp.2012.37","volume":"17","author":"M Ayalew","year":"2012","unstructured":"Ayalew, M. et al. Convergent functional genomics of schizophrenia: From comprehensive understanding to genetic risk prediction. Mol. Psychiatry 17, 887\u2013905 (2012).","journal-title":"Mol. Psychiatry"},{"key":"10391_CR47","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1007\/PL00000918","volume":"58","author":"P Ernfors","year":"2001","unstructured":"Ernfors, P. Local and target-derived actions of neurotrophins during peripheral nervous system development. Cell. Mol. Life Sci. 58, 1036\u20131044 (2001).","journal-title":"Cell. Mol. Life Sci."},{"key":"10391_CR48","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1016\/j.jpsychires.2008.01.010","volume":"42","author":"K Otsuki","year":"2008","unstructured":"Otsuki, K. et al. Altered expression of neurotrophic factors in patients with major depression. J. Psychiatr. Res. 42, 1145\u20131153 (2008).","journal-title":"J. Psychiatr. Res."},{"key":"10391_CR49","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.neulet.2018.08.005","volume":"684","author":"J Arabska","year":"2018","unstructured":"Arabska, J., \u0141ucka, A., Strzelecki, D. & Wysoki\u0144ski, A. In schizophrenia serum level of neurotrophin-3 (NT-3) is increased only if depressive symptoms are present. Neurosci. Lett. 684, 152\u2013155 (2018).","journal-title":"Neurosci. Lett."},{"key":"10391_CR50","doi-asserted-by":"publisher","first-page":"1234","DOI":"10.1093\/hmg\/ddn013","volume":"17","author":"JM Mercader","year":"2008","unstructured":"Mercader, J. M. et al. Association of NTRK3 and its interaction with NGF suggest an altered cross-regulation of the neurotrophin signaling pathway in eating disorders. Hum. Mol. Genet. 17, 1234\u20131244 (2008).","journal-title":"Hum. Mol. Genet."},{"key":"10391_CR51","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1046\/j.0022-3042.2001.00747.x","volume":"80","author":"J Lee","year":"2002","unstructured":"Lee, J., Seroogy, K. B. & Mattson, M. P. Dietary restriction enhances neurotrophin expression and neurogenesis in the hippocampus of adult mice. J. Neurochem. 80, 539\u2013547 (2002).","journal-title":"J. Neurochem."},{"key":"10391_CR52","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/j.comppsych.2013.04.014","volume":"54","author":"S Jim\u00e9nez-Murcia","year":"2013","unstructured":"Jim\u00e9nez-Murcia, S. et al. Pathological gambling in eating disorders: Prevalence and clinical implications. Compr. Psychiatry 54, 1053\u20131060 (2013).","journal-title":"Compr. Psychiatry"},{"key":"10391_CR53","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/erv.2207","volume":"21","author":"KM von Ranson","year":"2013","unstructured":"von Ranson, K. M., Wallace, L. M., Holub, A. & Hodgins, D. C. Eating disorders, substance use disorders, and impulsiveness among disordered gamblers in a community sample. Eur. Eat. Disord. Rev. 21, 148\u2013154 (2013).","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10391_CR54","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1016\/j.comppsych.2007.03.008","volume":"48","author":"EM \u00c1lvarez-Moya","year":"2007","unstructured":"\u00c1lvarez-Moya, E. M. et al. Comparison of personality risk factors in bulimia nervosa and pathological gambling. Compr. Psychiatry 48, 452\u2013457 (2007).","journal-title":"Compr. Psychiatry"},{"key":"10391_CR55","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1556\/2006.6.2017.051","volume":"6","author":"A del Pino-Guti\u00e9rrez","year":"2017","unstructured":"del Pino-Guti\u00e9rrez, A. et al. The relevance of personality traits in impulsivity-related disorders: From substance use disorders and gambling disorder to bulimia nervosa. J. Behav. Addict. 6, 396\u2013405 (2017).","journal-title":"J. Behav. Addict."},{"key":"10391_CR56","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1002\/erv.2340","volume":"23","author":"S Jim\u00e9nez-Murcia","year":"2015","unstructured":"Jim\u00e9nez-Murcia, S. et al. Differences and similarities between bulimia nervosa, compulsive buying and gambling disorder. Eur. Eat. Disord. Rev. 23, 111\u2013118 (2015).","journal-title":"Eur. Eat. Disord. Rev."},{"key":"10391_CR57","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1359\/jbmr.1999.14.2.248","volume":"14","author":"H Sasaki-Iwaoka","year":"1999","unstructured":"Sasaki-Iwaoka, H. et al. A trans-acting enhancer modulates estrogen-mediated transcription of reporter genes in osteoblasts. J. Bone Miner. Res. 14, 248\u2013255 (1999).","journal-title":"J. Bone Miner. Res."},{"key":"10391_CR58","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1016\/0092-8674(89)90110-4","volume":"58","author":"H-P M\u00fcller","year":"1989","unstructured":"M\u00fcller, H.-P., Sogo, J. & Schaffner, W. An enhancer stimulates transcription in Trans when attached to the promoter via a protein bridge. Cell 58, 767\u2013777 (1989).","journal-title":"Cell"},{"key":"10391_CR59","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1186\/s13073-014-0085-3","volume":"6","author":"O Corradin","year":"2014","unstructured":"Corradin, O. & Scacheri, P. C. Enhancer variants: Evaluating functions in common disease. Genome Med. 6, 85 (2014).","journal-title":"Genome Med."},{"key":"10391_CR60","doi-asserted-by":"publisher","first-page":"3472","DOI":"10.1038\/s41467-019-11412-5","volume":"10","author":"AD Johnston","year":"2019","unstructured":"Johnston, A. D., Sim\u00f5es-Pires, C. A., Thompson, T. V., Suzuki, M. & Greally, J. M. Functional genetic variants can mediate their regulatory effects through alteration of transcription factor binding. Nat. Commun. 10, 3472 (2019).","journal-title":"Nat. Commun."},{"key":"10391_CR61","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1016\/j.pnpbp.2010.05.026","volume":"34","author":"SC Cho","year":"2010","unstructured":"Cho, S. C. et al. Neurotrophin-3 gene, intelligence, and selective attention deficit in a Korean sample with attention-deficit\/hyperactivity disorder. Prog. Neuro-Psychopharmacol. Biol. Psychiatry 34, 1065\u20131069 (2010).","journal-title":"Prog. Neuro-Psychopharmacol. Biol. Psychiatry"},{"key":"10391_CR62","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/01677063.2015.1099651","volume":"29","author":"M Liu","year":"2015","unstructured":"Liu, M. et al. Polymorphisms of the neurotrophic factor-3 (NTF-3) in Alzheimer\u2019s disease: rs6332 associated with onset time and rs6489630 T allele exhibited a protective role. J. Neurogenet. 29, 183\u2013187 (2015).","journal-title":"J. Neurogenet."},{"key":"10391_CR63","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1016\/j.psychres.2016.10.071","volume":"246","author":"M Fats\u00e9as","year":"2016","unstructured":"Fats\u00e9as, M. et al. Addiction severity pattern associated with adult and childhood Attention Deficit Hyperactivity Disorder (ADHD) in patients with addictions. Psychiatry Res. 246, 656\u2013662 (2016).","journal-title":"Psychiatry Res."},{"key":"10391_CR64","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s00702-016-1566-x","volume":"123","author":"W Retz","year":"2016","unstructured":"Retz, W., Ringling, J., Retz-Junginger, P., Vogelgesang, M. & R\u00f6sler, M. Association of attention-deficit\/hyperactivity disorder with gambling disorder. J. Neural Transm. 123, 1013\u20131019 (2016).","journal-title":"J. Neural Transm."},{"key":"10391_CR65","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1007\/s11469-018-9986-5","volume":"18","author":"RC Reid","year":"2018","unstructured":"Reid, R. C., Campos, M., Selochan, N. & Fong, T. W. Characteristics of treatment seeking problem gamblers with adult ADHD. Int. J. Ment. Health Addict. 18, 875\u2013890 (2018).","journal-title":"Int. J. Ment. Health Addict."},{"key":"10391_CR66","doi-asserted-by":"publisher","DOI":"10.1177\/1087054719894378","author":"G Mestre-Bach","year":"2019","unstructured":"Mestre-Bach, G. et al. The role of ADHD symptomatology and emotion dysregulation in gambling disorder. J. Atten. Disord. https:\/\/doi.org\/10.1177\/1087054719894378 (2019).","journal-title":"J. Atten. Disord."},{"key":"10391_CR67","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1038\/sj.mp.4000500","volume":"4","author":"DE Comings","year":"1999","unstructured":"Comings, D. E. Molecular heterosis as the explanation for the controversy about the effect of the DRD2 gene on dopamine D2 receptor density. Mol. Psychiatry 4, 213\u2013215 (1999).","journal-title":"Mol. Psychiatry"},{"key":"10391_CR68","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1006\/mgme.2000.3015","volume":"71","author":"DE Comings","year":"2000","unstructured":"Comings, D. E. & MacMurray, J. P. Molecular heterosis: A review. Mol. Genet. Metab. 71, 19\u201331 (2000).","journal-title":"Mol. Genet. Metab."},{"key":"10391_CR69","doi-asserted-by":"publisher","first-page":"14297","DOI":"10.1073\/pnas.2335926100","volume":"100","author":"MW Sleeman","year":"2003","unstructured":"Sleeman, M. W. et al. Ciliary neurotrophic factor improves diabetic parameters and hepatic steatosis and increases basal metabolic rate in db\/db mice. Proc. Natl. Acad. Sci. 100, 14297\u201314302 (2003).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10391_CR70","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1126\/science.1115360","volume":"310","author":"MV Kokoeva","year":"2005","unstructured":"Kokoeva, M. V., Yin, H. & Flier, J. S. Neurogenesis in the hypothalamus of adult mice: Potential role in energy balance. Science 310, 679\u2013683 (2005).","journal-title":"Science"},{"key":"10391_CR71","doi-asserted-by":"publisher","first-page":"4652","DOI":"10.1073\/pnas.061034298","volume":"98","author":"PD Lambert","year":"2001","unstructured":"Lambert, P. D. et al. Ciliary neurotrophic factor activates leptin-like pathways and reduces body fat, without cachexia or rebound weight gain, even in leptin-resistant obesity. Proc. Natl. Acad. Sci. 98, 4652\u20134657 (2001).","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10391_CR72","doi-asserted-by":"publisher","first-page":"R1422","DOI":"10.1152\/ajpregu.1996.271.5.R1422","volume":"271","author":"D Martin","year":"1996","unstructured":"Martin, D. et al. Cachectic effect of ciliary neurotrophic factor on innervated skeletal muscle. Am. J. Physiol. Integr. Comp. Physiol. 271, R1422\u2013R1428 (1996).","journal-title":"Am. J. Physiol. Integr. Comp. Physiol."},{"key":"10391_CR73","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1210\/endo.139.2.5723","volume":"139","author":"B Xu","year":"1998","unstructured":"Xu, B. et al. Anorectic effects of the cytokine, ciliary neurotropic factor, are mediated by hypothalamic neuropeptide Y: Comparison with leptin*. Endocrinology 139, 466\u2013473 (1998).","journal-title":"Endocrinology"},{"key":"10391_CR74","doi-asserted-by":"publisher","first-page":"1290","DOI":"10.1093\/emboj\/19.6.1290","volume":"19","author":"SG Kernie","year":"2000","unstructured":"Kernie, S. G. BDNF regulates eating behavior and locomotor activity in mice. EMBO J. 19, 1290\u20131300 (2000).","journal-title":"EMBO J."},{"key":"10391_CR75","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1038\/nn1073","volume":"6","author":"B Xu","year":"2003","unstructured":"Xu, B. et al. Brain-derived neurotrophic factor regulates energy balance downstream of melanocortin-4 receptor. Nat. Neurosci. 6, 736\u2013742 (2003).","journal-title":"Nat. Neurosci."},{"key":"10391_CR76","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1006\/abbi.1995.1460","volume":"322","author":"M Haniu","year":"1995","unstructured":"Haniu, M. et al. Extracellular domain of neurotrophin receptor trkB: Disulfide structure, N-glycosylation sites, and ligand binding. Arch. Biochem. Biophys. 322, 256\u2013264 (1995).","journal-title":"Arch. Biochem. Biophys."},{"key":"10391_CR77","doi-asserted-by":"publisher","first-page":"1187","DOI":"10.1038\/nn1336","volume":"7","author":"GSH Yeo","year":"2004","unstructured":"Yeo, G. S. H. et al. A de novo mutation affecting human TrkB associated with severe obesity and developmental delay. Nat. Neurosci. 7, 1187\u20131189 (2004).","journal-title":"Nat. Neurosci."},{"key":"10391_CR78","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1038\/nrm.2016.104","volume":"17","author":"AD Schmitt","year":"2016","unstructured":"Schmitt, A. D., Hu, M. & Ren, B. Genome-wide mapping and analysis of chromosome architecture. Nat. Rev. Mol. Cell Biol. 17, 743\u2013755 (2016).","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10391_CR79","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nmeth.4325","volume":"14","author":"M Forcato","year":"2017","unstructured":"Forcato, M. et al. Comparison of computational methods for Hi-C data analysis. Nat. Methods 14, 679\u2013685 (2017).","journal-title":"Nat. Methods"},{"key":"10391_CR80","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1101\/gad.281964.116","volume":"30","author":"A Denker","year":"2016","unstructured":"Denker, A. & de Laat, W. The second decade of 3C technologies: Detailed insights into nuclear organization. Genes Dev. 30, 1357\u20131382 (2016).","journal-title":"Genes Dev."},{"key":"10391_CR81","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08940-5","volume":"10","author":"WW Greenwald","year":"2019","unstructured":"Greenwald, W. W. et al. Subtle changes in chromatin loop contact propensity are associated with differential gene regulation and expression. Nat. Commun. 10, 1\u201317 (2019).","journal-title":"Nat. Commun."},{"key":"10391_CR82","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.neuropharm.2008.06.059","volume":"56","author":"SJ Russo","year":"2009","unstructured":"Russo, S. J., Mazei-Robison, M. S., Ables, J. L. & Nestler, E. J. Neurotrophic factors and structural plasticity in addiction. Neuropharmacology 56, 73\u201382 (2009).","journal-title":"Neuropharmacology"},{"key":"10391_CR83","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00702-003-0100-0","volume":"111","author":"UE Lang","year":"2004","unstructured":"Lang, U. E., Jockers-Scherubl, M. C. & Hellweg, R. State of the art of the neurotrophin hypothesis in psychiatric disorders: Implications and limitations. J. Neural Transm. 111, 387\u2013411 (2004).","journal-title":"J. Neural Transm."},{"key":"10391_CR84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1042\/CS20050163","volume":"110","author":"MV Chao","year":"2006","unstructured":"Chao, M. V., Rajagopal, R. & Lee, F. S. Neurotrophin signalling in health and disease. Clin. Sci. 110, 167\u2013173 (2006).","journal-title":"Clin. Sci."},{"key":"10391_CR85","volume-title":"Entrevista Cl\u00ednica Estructurada para los trastornos del Eje I del DSM-IV, Versi\u00f3n CL\u00cdNICA (SCID-I-VC)","author":"MB First","year":"1997","unstructured":"First, M. B., Spitzer, R. L., Williams, J. & Gibbon, M. Entrevista Cl\u00ednica Estructurada para los trastornos del Eje I del DSM-IV, Versi\u00f3n CL\u00cdNICA (SCID-I-VC) (Masson, 1997)."},{"key":"10391_CR86","volume-title":"Diagnostic and Statistical Manual of Mental Disorders","author":"American Psychiatric association (APA)","year":"2000","unstructured":"American Psychiatric association (APA). Diagnostic and Statistical Manual of Mental Disorders 4th edn. (American Psychiatric Association, 2000).","edition":"4"},{"key":"10391_CR87","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1176\/appi.ajp.160.1.180","volume":"160","author":"R Stinchfield","year":"2003","unstructured":"Stinchfield, R. Reliability, validity, and classification accuracy of a measure of DSM-IV diagnostic criteria for pathological gambling. Am. J. Psychiatry 160, 180\u2013182 (2003).","journal-title":"Am. J. Psychiatry"},{"key":"10391_CR88","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/s10899-008-9104-x","volume":"25","author":"S Jim\u00e9nez-Murcia","year":"2009","unstructured":"Jim\u00e9nez-Murcia, S. et al. Reliability, validity, and classification accuracy of a spanish translation of a measure of DSM-IV diagnostic criteria for pathological gambling. J. Gambl. Stud. 25, 93\u2013104 (2009).","journal-title":"J. Gambl. Stud."},{"key":"10391_CR89","volume-title":"Protocols of Cognitive-Behaviour Therapy for Pathological Gambling and Other Behavioural Addictions","author":"S Jim\u00e9nez-Murcia","year":"2006","unstructured":"Jim\u00e9nez-Murcia, S., Aymam\u00ed-Sanrom\u00e0, M., G\u00f3mez-Pena, M., \u00c1lvarez-Moya, E. & Vallejo, J. Protocols of Cognitive-Behaviour Therapy for Pathological Gambling and Other Behavioural Addictions (Springer, 2006)."},{"key":"10391_CR90","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1093\/bioinformatics\/bth457","volume":"21","author":"JC Barrett","year":"2005","unstructured":"Barrett, J. C., Fry, B., Maller, J. & Daly, M. J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21, 263\u2013265 (2005).","journal-title":"Bioinformatics"},{"key":"10391_CR91","doi-asserted-by":"publisher","first-page":"2225","DOI":"10.1126\/science.1069424","volume":"296","author":"SB Gabriel","year":"2002","unstructured":"Gabriel, S. B. et al. The structure of haplotype blocks in the human genome. Science 296, 2225\u20132229 (2002).","journal-title":"Science"},{"key":"10391_CR92","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1093\/biomet\/73.3.751","volume":"73","author":"RJ Simes","year":"1986","unstructured":"Simes, R. J. An improved Bonferroni procedure for multiple tests of significance. Biometrika 73, 751\u2013754 (1986).","journal-title":"Biometrika"},{"key":"10391_CR93","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1038\/s41586-020-2493-4","volume":"583","author":"JE Moore","year":"2020","unstructured":"Moore, J. E. et al. Expanded encyclopaedias of DNA elements in the human and mouse genomes. Nature 583, 699\u2013710 (2020).","journal-title":"Nature"},{"key":"10391_CR94","doi-asserted-by":"publisher","first-page":"D142","DOI":"10.1093\/nar\/gkt997","volume":"42","author":"A Mathelier","year":"2014","unstructured":"Mathelier, A. et al. JASPAR 2014: an extensively expanded and updated open-access database of transcription factor binding profiles. Nucleic Acids Res. 42, D142\u2013D147 (2014).","journal-title":"Nucleic Acids Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10391-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10391-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T02:04:47Z","timestamp":1669341887000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-022-10391-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4,28]]},"references-count":94,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["10391"],"URL":"https:\/\/doi.org\/10.1038\/s41598-022-10391-w","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,4,28]]},"assertion":[{"value":"22 October 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 April 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 April 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"FFA received consultancy honoraria from Novo Nordisk and editorial honoraria as EIC from Wiley. The rest of the authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"6925"}}